Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Veletri fails to meet primary efficacy objective in RITZ-1

April 20, 2001

Inhibitors of sPLA2 described in recent patent literature by Shionogi

April 19, 2001

Clinical evaluation of antiarrhythmic agent RSD-1235 begun by Nortran

April 19, 2001

FDA review period for Remodulin NDA extended

April 19, 2001

Quinoline derivatives synthesized at Nippon Soda are potent and selective PDE5 inhibitors

April 12, 2001

Orion's Simdax receives favorable opinion in several E.U. countries

April 12, 2001

Natrecor scheduled for FDA advisory committee review

April 12, 2001

RWJ-58259 characterized simultaneously at ACS and in major scientific journal

April 10, 2001

AstraZeneca beta-blocker now available in U.S. for heart failure treatment

April 10, 2001

Bertek licenses beta-blocker nebivolol; new indications to be evaluated

April 9, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026